trustme.bro/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Certain vaccines confer only short-term protection due to rapid waning of neutralizing antibodies

the verdict
SUPPORTED
the evidence backs this
Recorded sources
5 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Multiple studies consistently demonstrate that vaccine-induced neutralizing antibody levels and clinical efficacy decline over time, necessitating booster doses to maintain protection.

The analysis

The claim that certain vaccines confer only short-term protection due to rapid antibody waning is strongly supported by recent literature on COVID-19 and respiratory vaccines, which document significant declines in antibody titers and efficacy within months. No retrieved papers refute this claim.

Evidence for · 5
Recorded source metadata

Biswas R, Roy A, Kayal T, Basu S, Ghosh S, Ramaiah S, Anbarasu A. Waning immunity and the future of booster vaccination strategies in global vaccine programs post COVID-19.. 2026. https://doi.org/10.1080/21645515.2026.2626088

Paper 0 notes that immunity and efficacy against diseases such as COVID-19 and influenza decrease over time, with short-term booster effects.

See more details
More for · 4
Recorded source metadata

Daniel J. Phillips, Maria D. Christodoulou, Shuo Feng, Andrew J. Pollard, Merryn Voysey, David Steinsaltz. Improved estimates of COVID-19 correlates of protection, antibody decay and vaccine efficacy waning: a joint modelling approach. 2024. https://doi.org/10.1101/2024.07.02.24309776

Paper 6 demonstrates that vaccine efficacy and anti-spike IgG antibody levels against COVID-19 wane significantly within months of vaccination.

Recorded source metadata

Demirel Ç, Kibar F, Dağlıoğlu G, Çetiner S, Candevir A, İnal AS, Yücel Karakaya SP, Görüroğlu Öztürk Ö, Gümüş HH, İnal TC. Long-Term Durability and Dynamics of Anti-S-RBD IgG Response in Healthcare Workers: A Comparative Analysis of Homologous and Heterologous SARS-CoV-2 Vaccination Schedules in a 1-Year Serial Cross-Sectional Study.. 2026. https://doi.org/10.12659/msm.952930

Paper 8 highlights that antibody titers wane significantly over time in mRNA-vaccinated individuals, necessitating booster strategies.

Recorded source metadata

Poh XY, Mah SYY, Yeoh AYY, Chavatte JM, Lim DRX, Tan CCY, Tang HL, Gandhi M, Rahman N, Rao S, Chia PY, Sadarangani SP, Chin YQ, Ng LFP, Renia L, Lin RTP, Lye DC, Wang LF, Tan CW, Young BE. NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variants.. 2026. https://doi.org/10.1080/21645515.2026.2638022

Paper 10 finds that neutralizing antibody levels against variants wane significantly by 12 months post-vaccination.

Recorded source metadata

Gurkšnienė V, Alčauskas T, Karosienė D, Urbonienė J, Majauskaitė F, Paulauskas M, Zablockienė B, Vitkus D, Jančorienė L. Dynamics and Protective Effectiveness of Serological Testing Among Healthcare Workers Vaccinated Against COVID-19.. 2026. https://doi.org/10.3390/medicina62050810

Paper 11 shows that antibody titers peak initially and then decline sharply over subsequent quarters, illustrating antibody waning.

The paper trail · every fact has a biography
first checked02 Aug 2026
judged → SUPPORTED · 8102 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.
trust me, bro: win the argument, pass the class, survive peer review.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt